相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report
Hyun-Sic Jo et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015
David R. Saxon et al.
OBESITY (2019)
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Minireview: CNS Mechanisms of Leptin Action
Jonathan N. Flak et al.
MOLECULAR ENDOCRINOLOGY (2016)
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
T. A. P. Lett et al.
MOLECULAR PSYCHIATRY (2012)
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
Marcelo O. Dietrich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
David B. Allison et al.
OBESITY (2012)
Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
Patrick M. O'Neil et al.
OBESITY (2012)
Anti-Obesity Drugs: A Review about Their Effects and Safety
Jun Goo Kang et al.
DIABETES & METABOLISM JOURNAL (2012)
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Meredith C. Fidler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
Johan Ferno et al.
PLOS ONE (2011)
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Robert J. Fountaine et al.
OBESITY (2010)
Appetite Suppressants, Cardiac Valve Disease and Combination Pharmacotherapy
Richard B. Rothman et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders - A systematic critical reappraisal
Mario Alvarez-Jimenez et al.
CNS DRUGS (2008)
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD
Xueliang Fan et al.
NEUROBIOLOGY OF DISEASE (2007)
Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective
Michael T. Compton et al.
HARVARD REVIEW OF PSYCHIATRY (2006)
The strategic use of gain- and loss-framed messages to promote healthy behavior: How theory can inform practice
Alexander J. Rothman et al.
JOURNAL OF COMMUNICATION (2006)
Meta-analysis: Pharmacologic treatment of obesity
ZP Li et al.
ANNALS OF INTERNAL MEDICINE (2005)
Drug insight: appetite suppressants
GA Bray
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Clozapine's effects on body weight and resting metabolic rate: a case series
RM Procyshyn et al.
SCHIZOPHRENIA RESEARCH (2004)
Topiramate and psychiatric adverse events in patients with epilepsy
M Mula et al.
EPILEPSIA (2003)
Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
D Gothelf et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Decrease of energy expenditure causes weight increase in olanzapine treatment - A case study
M Virkkunen et al.
PHARMACOPSYCHIATRY (2002)
分享论文
